Source link : https://www.newshealth.biz/health-news/novel-il-2-agent-shows-promise-in-advanced-solid-tumors/
A phase I study showed activity with WTX-124, a novel interleukin-2 (IL-2) prodrug, in patients with locally advanced or metastatic solid cancers whose tumors progressed after checkpoint inhibition. In this exclusive MedPage Today video, principal investigator Igor Puzanov, MD, of Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses findings from the study, which […]
Author : News Health
Publish date : 2024-07-02 15:06:00
Copyright for syndicated content belongs to the linked Source.
Categories